🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

High-throughput protein characterization by complementation using DNA barcoded fragment libraries doi.org/10.1038/s44320…

Bacterial live therapeutics for human diseases "focus on preclinical and clinical trials of bacteria-based therapeutic products" embopress.org/doi/full/10.10…

Bacterial live therapeutics for human diseases doi.org/10.1038/s44320…

Bacterial live therapeutics for human diseases | Molecular Systems Biology embopress.org/doi/full/10.10…

The simplistic beauty of #XCMS-#METLIN precursor ion filtering combined with MS/MS matching to deconvolve data on 935K+ molecular standards to a couple of hits Mol Syst Biol doi.org/10.1038/s44320… XCMS-METLIN local for your PC now available at massconsortium.com

🎉 Exciting news! Our paper on kidney cancer is now published! Check it out here: doi.org/10.1038/s44320…

Thrilled to share our latest work in Mol Syst Biol, featuring SIMPL2, a game-changing tool for detecting protein-protein interactions with unmatched sensitivity and specificity. Will be featured on the Feb 2025 cover of Mol Syst Biol! #DrugDiscovery #Innovation #SIMPL2

1/2025 Issue ➡️embopress.org/toc/17444292/2… L. pneumophila functional domains, analysis of human interactomes, increased sensitivity in cross-linking mass spectrometry Cover (SciStories LLC): cis-regulatory elements in #KSHV and proximity to target over viral lifecycle Britt Glaunsinger

Work by Bart Vanhaesebroeck lab showing oncogenic PIK3CAH1047R reduces biochemical information transfer, corrupts growth factor signaling specificity and increases single-cell heterogeneity ➡️ embopress.org/doi/full/10.10…

multiplexed drug screening in using biosensors identifies antivirals against 40 viruses ➡️ embopress.org/doi/full/10.10…

authors including Ava Khamseh lab introduce Stator for improved cell type and subtype identification by multiply labeling individual cells with additional state information ➡️ embopress.org/doi/full/10.10…

The kusterlab (Inactive)'s recent research provides a strong rationale for why the combination of gemcitabine and ATR inhibition may be useful for the treatment of #PDAC patients. 🖨️ Mol Syst Biol bit.ly/4jrPG0N

Deadlines are approaching for Keystone Symposia Precision #GenomeEngineering : Translating the #HumanGenome to the Clinic, this March in Killarney, where MSB editor Poonam Bheda will be present! See: keysym.us/KSGenomeEng25 #KSGenomeEng25

New Research Alert: Excited to share our work in Mol Syst Biol. For why the combination of gemcitabine and ATR inhibition may be useful for the treatment of #PDAC patients: pubmed.ncbi.nlm.nih.gov/39838187/ TU München Maximilian Reichert

New research from Link Lab reveals how metabolic mutations influence E. coli's antibiotic susceptibility ➡️ embopress.org/doi/full/10.10…

chemoresistance to DNA damaging agent Gemcitabine may be overcome with synergistic action of ATR kinase inhibitors ➡️ embopress.org/doi/full/10.10…

fast, reversible evolution of bacterial resistance to antibiotics is driven by epigenetic modifications while slow, irreversible evolution occurs via mutations in metabolic genes ➡️ embopress.org/doi/full/10.10…

I’m very much done with this app but here’s something for which I’m willing to come back & tweet… Our paper on the evolution of gene is just accepted at Mol Syst Biol !🥳 Final version coming soon!

Like EMBO, find us now on the alternative platform where we will keep Molecular Systems Biology news and published articles updated!